Patterns of failure after stereotactic body radiotherapy to non-spine bone metastases

被引:0
作者
Perez-Montero, Hector [1 ]
Lozano, Alicia [1 ]
de Blas, Rodolfo [2 ]
Hernandez, Javier [3 ]
Mera, Arantxa [4 ]
Guedea, Ferran [1 ]
Navarro-Martin, Arturo [1 ]
机构
[1] Catalan Inst Oncol, Radiat Oncol Dept, Avinguda Gran Via LHospitalet 199-203, Barcelona 08908, Spain
[2] Catalan Inst Oncol, Med Phys & Radiat Protect Dept, Avinguda Gran Via LHospitalet 199-203, Barcelona 08908, Spain
[3] Bellvitge Univ Hosp, Radiodiagnost Dept, Carrer Feixa Llarga W-N, Barcelona 08907, Spain
[4] Hosp Santa Creu & Sant Pau, Radiat Oncol Dept, St Quinti 89, Barcelona 08025, Spain
关键词
Stereotactic body radiotherapy; Bone metastases; Recurrence patterns; Contouring guidelines; Local control; RADIATION-THERAPY; BREAST-CANCER; DELINEATION; VOLUME; MICROMETASTASES; RECOMMENDATIONS; MULTICENTER; RECURRENCE; DISEASE; IMPACT;
D O I
10.1007/s12094-025-03878-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purposeStereotactic body radiotherapy (SBRT) has proven useful for non-spine bone metastases (NSBM). We analyzed local relapse rates and patterns of failure after NSBM-SBRT, contrasting our results with existing contouring guidelines.Materials and methodsWe conducted a retrospective analysis of NSBM-SBRT treatments performed between 2013 and 2024 in a single institution. Clinical, pathologic, and treatment-related data were collected. Failure patterns were assessed based on imaging tests and categorized as in-field, marginal/out-of-field.ResultsAmong 119 NSBM-SBRT treatments in 85 patients, the most common primary tumors were prostate (36.1%) and breast cancer (24.4%). The coxal bone was the predominant metastatic site (52.9%). The median follow-up was 32.8 months. OS rates at 1, 2, and 3 years were 90.1%, 83.5%, and 75.8%, respectively. Twenty seven relapses were observed in the treated bone with a median recurrent tumor volume of 9.9 cm3 and a median time to recurrence of 15.1 months. Relapse-free survival in the treated bone was 89.4%, 78.5%, and 74.2% at 1, 2, and 3 years, respectively. Median recurrent tumor volume within the CTV was 50.6% and the median distance from the relapse center to the initial tumor was 11.4 mm.ConclusionNSBM-SBRT provides effective local control with relapses often occurring near the initial tumor lesion. While adherence to existing contouring guidelines captures most scenarios, consideration of larger CTV expansions may be warranted in cases with poorer prognosis. Further studies are needed to identify risk factors for relapses outside the margins and optimize volume delineation in these scenarios.
引用
收藏
页数:8
相关论文
共 43 条
  • [1] Bone marrow micrometastases in different solid tumors: Pathogenesis and importance
    Athanassiadou, Pauline
    Grapsa, Dimitra
    [J]. SURGICAL ONCOLOGY-OXFORD, 2008, 17 (03): : 153 - 164
  • [2] Stereotactic body radiation therapy: The report of AAPM Task Group 101
    Benedict, Stanley H.
    Yenice, Kamil M.
    Followill, David
    Galvin, James M.
    Hinson, William
    Kavanagh, Brian
    Keall, Paul
    Lovelock, Michael
    Meeks, Sanford
    Papiez, Lech
    Purdie, Thomas
    Sadagopan, Ramaswamy
    Schell, Michael C.
    Salter, Bill
    Schlesinger, David J.
    Shiu, Almon S.
    Solberg, Timothy
    Song, Danny Y.
    Stieber, Volker
    Timmerman, Robert
    Tome, Wolfgang A.
    Verellen, Dirk
    Wang, Lu
    Yin, Fang-Fang
    [J]. MEDICAL PHYSICS, 2010, 37 (08) : 4078 - 4101
  • [3] Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure
    Chang, Eric L.
    Shiu, Almon S.
    Mendel, Ehud
    Mathews, Leni A.
    Mahajan, Anita
    Allen, Pamela K.
    Weinberg, Jeffrey S.
    Brown, Barry W.
    Wang, Xin Shelly
    Woo, Shiao Y.
    Cleeland, Charles
    Maor, Moshe H.
    Rhines, Laurence D.
    [J]. JOURNAL OF NEUROSURGERY-SPINE, 2007, 7 (02) : 151 - 160
  • [4] Trends in Diagnosis and Surgical Treatment of Bone Metastases among Orthopedic Surgeons
    Ciechanowicz, Dawid
    Kotrych, Daniel
    Dabrowski, Filip
    Mazurek, Tomasz
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (15)
  • [5] Pathophysiology of bone metastases from solid malignancies
    Clezardin, Philippe
    [J]. JOINT BONE SPINE, 2017, 84 (06) : 677 - 684
  • [6] Bone metastases
    Coleman, Robert E.
    Croucher, Peter I.
    Padhani, Anwar R.
    Clezardin, Philippe
    Chow, Edward
    Fallon, Marie
    Guise, Theresa
    Colangeli, Simone
    Capanna, Rodolfo
    Costa, Luis
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2020, 6 (01)
  • [7] International Spine Radiosurgery Consortium Consensus Guidelines for Target Volume Definition in Spinal Stereotactic Radiosurgery
    Cox, Brett W.
    Spratt, Daniel E.
    Lovelock, Michael
    Bilsky, Mark H.
    Lis, Eric
    Ryu, Samuel
    Sheehan, Jason
    Gerszten, Peter C.
    Chang, Eric
    Gibbs, Iris
    Soltys, Scott
    Sahgal, Arjun
    Deasy, Joe
    Flickinger, John
    Quader, Mubina
    Mindea, Stefan
    Yamada, Yoshiya
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (05): : E597 - E605
  • [8] International consensus recommendations for target volume delineation specific to sacral metastases and spinal stereotactic body radiation therapy (SBRT)
    Dunne, Emma M.
    Sahgal, Arjun
    Lo, Simon S.
    Bergman, Alanah
    Kosztyla, Robert
    Dea, Nicolas
    Chang, Eric L.
    Chang, Ung-Kyu
    Chao, Samuel T.
    Faruqi, Salman
    Ghia, Amol J.
    Redmond, Kristin J.
    Soltys, Scott G.
    Liu, Mitchell C.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2020, 145 : 21 - 29
  • [9] Understanding the Bone in Cancer Metastasis
    Fornetti, Jaime
    Welm, Alana L.
    Stewart, Sheila A.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 (12) : 2099 - 2113
  • [10] Inter-observer agreement in GTV delineation of bone metastases on CT and impact of MR imaging: A multicenter study
    Gerlich, A. S.
    van der Velden, J. M.
    Kotte, A. N. T. J.
    Tseng, C. L.
    Fanetti, G.
    Eppinga, W. S. C.
    Kasperts, N.
    Intven, M. P. W.
    Pameijer, F. A.
    Philippens, M. E. P.
    Verkooijen, H. M.
    Seravalli, E.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2018, 126 (03) : 534 - 540